Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Adipose-Derived Stem Cells as a Tool in Cell-Based Therapies.

Bajek A, Gurtowska N, Olkowska J, Kazmierski L, Maj M, Drewa T.

Arch Immunol Ther Exp (Warsz). 2016 Dec;64(6):443-454. Epub 2016 May 13. Review.

2.

Does the Harvesting Technique Affect the Properties of Adipose-Derived Stem Cells?-The Comparative Biological Characterization.

Bajek A, Gurtowska N, Olkowska J, Maj M, Kaźmierski Ł, Bodnar M, Marszałek A, Dębski R, Drewa T.

J Cell Biochem. 2017 May;118(5):1097-1107. doi: 10.1002/jcb.25724. Epub 2017 Jan 5.

PMID:
27608167
3.

Does the liposuction method influence the phenotypic characteristic of human adipose-derived stem cells?

Bajek A, Gurtowska N, Gackowska L, Kubiszewska I, Bodnar M, Marszałek A, Januszewski R, Michalkiewicz J, Drewa T.

Biosci Rep. 2015 May 14;35(3). pii: e00212. doi: 10.1042/BSR20150067.

4.

Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine.

Bajek A, Olkowska J, Gurtowska N, Kloskowski T, Walentowicz-Sadlecka M, Sadlecki P, Grabiec M, Drewa T.

Expert Opin Biol Ther. 2014 Jun;14(6):831-9. doi: 10.1517/14712598.2014.898749. Epub 2014 Mar 22. Review.

PMID:
24655038
5.

How to isolate urothelial cells? Comparison of four different methods and literature review.

Kloskowski T, Uzarska M, Gurtowska N, Olkowska J, Joachimiak R, Bajek A, Gagat M, Grzanka A, Bodnar M, Marszałek A, Drewa T.

Hum Cell. 2014 Apr;27(2):85-93. doi: 10.1007/s13577-013-0070-y. Epub 2013 Dec 25. Review.

PMID:
24368576
6.

Carboplatin and sodium butyrate, separate--yes, but combined--never.

Gurtowska N, Kloskowski T, Olkowska J, Bajek A, Debski R, Zielaskowska J, Drewa T.

Acta Pol Pharm. 2013 Jan-Feb;70(1):153-61.

7.

Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC.

Kloskowski T, Gurtowska N, Olkowska J, Nowak JM, Adamowicz J, Tworkiewicz J, Dębski R, Grzanka A, Drewa T.

Int J Oncol. 2012 Dec;41(6):1943-9. doi: 10.3892/ijo.2012.1653. Epub 2012 Oct 4.

8.

Does aging of mesenchymal stem cells limit their potential application in clinical practice?

Bajek A, Czerwinski M, Olkowska J, Gurtowska N, Kloskowski T, Drewa T.

Aging Clin Exp Res. 2012 Oct;24(5):404-11. doi: 10.3275/8424. Epub 2012 May 16. Review.

PMID:
22595834
9.

[Identification of circulating tumor cells as a promising method of genitourinary cancer diagnosis].

Gurtowska N, Bajek A, Olkowska J, Drewa T.

Postepy Hig Med Dosw (Online). 2012 Dec 7;66:983-90. Review. Polish.

10.

The influence of ciprofloxacin on viability of A549, HepG2, A375.S2, B16 and C6 cell lines in vitro.

Kloskowski T, Gurtowska N, Nowak M, Joachimiak R, Bajek A, Olkowska J, Drewa T.

Acta Pol Pharm. 2011 Nov-Dec;68(6):859-65.

11.

Ciprofloxacin as a prophylactic agent against prostate cancer: a "two hit" hypothesis.

Kloskowski T, Gurtowska N, Bajek A, Drewa T.

Med Hypotheses. 2012 Feb;78(2):235-8. doi: 10.1016/j.mehy.2011.10.034. Epub 2011 Nov 17.

PMID:
22098728
12.

Role of calcium and calmodulin in reaction of gastric fundus contraction.

Gajdus M, Szadujkis-Szadurski L, Szadujkis-Szadurski R, Glaza I, Zalewska M, Szadujkis-Szadurska K, Gurtowska N.

Postepy Hig Med Dosw (Online). 2011 Sep 5;65:569-73.

13.

Activity of guanylyl cyclase activators on the reaction of tracheal smooth muscle contraction.

Glaza I, Szadujkis-Szadurski L, Szadujkis-Szadurski R, Gajdus M, Rzepka A, Gurtowska N.

Postepy Hig Med Dosw (Online). 2011 Aug 5;65:496-500.

14.

Ciprofloxacin criteria in antimicrobial prophylaxis and bladder cancer recurrence.

Gurtowska N, Kloskowski T, Drewa T.

Med Sci Monit. 2010 Oct;16(10):RA218-23. Review.

PMID:
20885364
15.

Does ciprofloxacin have an obverse and a reverse?

Kloskowski T, Gurtowska N, Drewa T.

Pulm Pharmacol Ther. 2010 Oct;23(5):373-5. doi: 10.1016/j.pupt.2010.02.005. Epub 2010 Mar 6. Review.

PMID:
20211752

Supplemental Content

Loading ...
Support Center